Published in Thromb Res on October 15, 1989
Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med (2000) 5.43
Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) (1977) 3.20
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol (1988) 2.60
Therapeutic defibrination in the treatment of thrombotic disease. Lancet (1968) 2.40
The nephrotic syndrome associated with secondary syphilis. An immune deposit disease. Am J Med (1970) 2.37
Highly sensitive thromboplastins do not improve INR precision. Am J Clin Pathol (1998) 2.03
A comparative analysis of pulmonary perfusion scans with pulmonary angiograms. Am Heart J (1976) 1.93
Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine (Baltimore) (1981) 1.88
Current concepts: guidelines for the use of thrombolytic agents. N Engl J Med (1979) 1.82
Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol (1978) 1.79
The clinical features of submassive and massive pulmonary emboli. Am J Med (1977) 1.77
Letter: Dilantin, agranulocytosis, and phagocytic marrow histiocytes. Ann Intern Med (1976) 1.63
Disseminated intravascular coagulation and portal hypertension following pancreatic islet autotransplantation. Ann Surg (1980) 1.58
Typhoid fever. Studies of blood coagulation, bacteremia, and endotoxemia. Arch Intern Med (1978) 1.52
Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients. Ann Intern Med (1976) 1.46
Oxidative damage in age-related macular degeneration. Histol Histopathol (2007) 1.44
Acetaminophen and warfarin: undesirable synergy. JAMA (1998) 1.43
Purification and characterization of two isoforms of Acanthamoeba profilin. J Cell Biol (1986) 1.41
Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrow. Pharmacogenomics J (2003) 1.41
The effect of arvin on blood coagulation factors. Br J Haematol (1968) 1.39
Trousseau's syndrome. Devastating coagulopathy in the absence of heparin. Am J Med (1985) 1.38
Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention, and treatment. Am Heart J (1982) 1.34
Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation. J Biol Chem (1982) 1.32
Disorganization of cultured vascular endothelial cell monolayers by fibrinogen fragment D. Science (1985) 1.19
Amino acid analysis by HPLC: optimized conditions for chromatography of phenylthiocarbamyl derivatives. Anal Biochem (1986) 1.18
Localization of a fibrinogen calcium binding site between gamma-subunit positions 311 and 336 by terbium fluorescence. J Biol Chem (1985) 1.16
The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. A clinicopathologic study of 17 autopsied patients. Ann Intern Med (1979) 1.16
Microscopic method for assaying F cell production: illustrative changes during infancy and in aplastic anemia. Blood (1978) 1.15
Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem (1988) 1.12
Carbohydrate structure of human fibrinogen. Use of 300-MHz 1H-NMR to characterize glycosidase-treated glycopeptides. J Biol Chem (1982) 1.07
Disseminated intravascular coagulation. Johns Hopkins Med J (1980) 1.06
Disseminated intravascular coagulation during heparin therapy. Ann Intern Med (1974) 1.01
Cimetidine potentiation of the hypoprothrombinemic effect of warfarin. Ann Intern Med (1979) 1.00
Fibrinogen sialic acid residues are low affinity calcium-binding sites that influence fibrin assembly. J Biol Chem (1989) 1.00
Microwave technology for the rapid thawing of frozen blood components. Am J Clin Pathol (1985) 1.00
Pseudothrombocytopenia: manifestation of a new type of platelet agglutinin. Blood (1973) 1.00
Multivariate time series projections of parameterized age-specific fertility rates. J Am Stat Assoc (1989) 0.98
Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection. J Clin Invest (1996) 0.98
Heparin-associated thrombocytopenia: a comparison of three heparin preparations. N Engl J Med (1980) 0.98
Variations in the frequency of fetal hemoglobin-bearing erythrocytes (F-cells) in well adults, pregnant women, and adult leukemics. Johns Hopkins Med J (1975) 0.97
The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man. J Lab Clin Med (1978) 0.96
Metastatic intravagal paraganglioma. Case report and review of the literature. Am J Med (1985) 0.95
The synergistic activity of intra-amniotic prostaglandin F2 alpha and urea in the midtrimester elective abortion. Am J Obstet Gynecol (1974) 0.95
Thrombolytic therapy for inferior vena cava thrombosis in paroxysmal nocturnal hemoglobinuria. Ann Intern Med (1985) 0.95
Editorial: Thrombocytopenia occurring during heparin therapy. N Engl J Med (1976) 0.92
Heparin-induced coagulopathy. J Lab Clin Med (1977) 0.91
Effects of arvin on blood platelets. In vitro and in vivo studies. J Lab Clin Med (1972) 0.90
Pulmonary embolism: progress and problems. Am J Med (1982) 0.89
Megakaryocyte-targeted synthesis of the integrin beta(3)-subunit results in the phenotypic correction of Glanzmann thrombasthenia. Blood (2000) 0.88
Natural history of autologous blood clot embolization in swine. Invest Radiol (1976) 0.88
Polymyalgia rheumatica. Johns Hopkins Med J (1967) 0.88
Keyhole limpet hemocyanin: structural and functional characterization of two different subunits and multimers. Comp Biochem Physiol B Biochem Mol Biol (1996) 0.88
Chronic myelocytic leukemia with two Philadelphia chromosomes and prominent peripheral lymphadenopathy. Blood (1967) 0.88
A comparison of hyperacute canine renal allograft and sheep-to-dog xenograft rejection. Transplantation (1972) 0.88
Blood fibrinolytic activity during arvin therapy. Br J Haematol (1969) 0.87
Direct spectrophotometry of serum hemoglobin: an Allen correction compared with a three-wavelength polychromatic analysis. Clin Chem (1984) 0.87
Binding and endocytosis of glycoproteins and neoglycoproteins by isolated rabbit hepatocytes. Biochem J (1983) 0.86
Intracellular growth factors in polycythemia vera and other myeloproliferative disorders. Proc Natl Acad Sci U S A (1987) 0.86
Cytogenetic and morphologie abnormalities in human bone marrow cells during cytosine arabinoside therapy. Blood (1966) 0.86
Streptokinase salvage of renal function after renal vein thrombosis. Ann Intern Med (1984) 0.86
Diagnosis and treatment of anticoagulant-related adrenal hemorrhage. Am J Hematol (1981) 0.85
Post-transfusion purpura: a report of five patients and a review of the pathogenesis and management. Am J Hematol (1986) 0.85
Disseminated intravascular coagulation in prostatic carcinoma reversed by ketoconazole. JAMA (1987) 0.85
Autotransfusion of shed mediastinal blood after cardiac surgery: a prospective study. J Thorac Cardiovasc Surg (1978) 0.85
Familial multiple coagulation factor deficiencies. II. Combined factor VIII, IX, and XI deficiency and combined factor IX and XI deficiency: two previously uncharacterized familial multiple factor deficiency syndromes. Semin Thromb Hemost (1981) 0.85
Abnormalities of the spleen and liver in patients with hemophilia. Am J Hematol (1983) 0.84
The normal and morbid biology of fibrinogen. Am J Med (1989) 0.84
Management of priapism by therapeutic defibrination. N Engl J Med (1969) 0.84
The use of ancrod to prevent thrombosis on prosthetic heart valves. An experimental study. Thorax (1970) 0.84
Stimulation of fibrinogen synthesis: a possible functional role of fibrinogen degradation products. Blood (1980) 0.84
Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits. Am J Physiol (1989) 0.83
The effect of homologous thrombin and fibrinogen degradation products on fibrinogen synthesis in rabbits. J Lab Clin Med (1979) 0.83
Breath ethane: a specific indicator of free-radical-mediated lipid peroxidation following reperfusion of the ischemic liver. Free Radic Biol Med (1992) 0.83
Obstetric complications in a patient with Bernard-Soulier syndrome. Am J Obstet Gynecol (1991) 0.83
The urokinase-streptokinase pulmonary embolism trial (phase II) results. Circulation (1974) 0.83
Coronary thrombolysis with recombinant tissue-type plasminogen activator. A hematologic and pharmacologic study. Ann Intern Med (1985) 0.83
The effect of Arvin on experimental immune arthritis in rabbits. Br J Exp Pathol (1970) 0.82
Yersinia pestis infection in Vietnam. I. Clinical and hematologic aspects. J Infect Dis (1974) 0.82
Fibrinogen synthesis in rabbits: effects of altered levels of circulating fibrinogen. Am J Physiol (1977) 0.82
Control of heparin therapy in open-heart surgery. J Thorac Cardiovasc Surg (1974) 0.82
A unique circulating inhibitor with specificity for coagulation factor X. Am J Med (1992) 0.82
Pseudoviral inclusion bodies in acute leukemia. A report of two cases. J Natl Cancer Inst (1967) 0.81
A kinetic analysis of fibrinogenolysis during plasminogen activator therapy. Clin Pharmacol Ther (1987) 0.81
Polymerization defect of fibrinogen Baltimore III due to a gamma Asn308----Ile mutation. Blood (1990) 0.81
Defibrinogenation after intra-amniotic injection of hypertonic saline. N Engl J Med (1972) 0.81
In vivo behaviour of the coagulant enzyme from Agkistrodon rhodostoma venom: studies using 131-I-'arvin'. Br J Haematol (1969) 0.81
Accuracy of screening for pulmonary embolism in the emergency room. Respiration (1979) 0.81
Respiratory failure in acute pancreatitis: the role of free fatty acids. Surgery (1980) 0.81
Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and B. J Lab Clin Med (1979) 0.80
Studies on the pathophysiology of posttransfusion purpura. Blood (1986) 0.80
H-Ras oncogene counteracts the growth-inhibitory effect of genistein in T24 bladder carcinoma cells. Br J Cancer (2005) 0.80
Unexplained hemolytic anemia associated with pregnancy. Am J Obstet Gynecol (1983) 0.80
Prevention of experimental postoperative adhesions by ancrod defibrinogenation. J Surg Res (1975) 0.79
Abortion and coagulation by prostaglandin. Intra-amniotic dinoprost tromethamine effect on the coagulation and fibrinolytic systems. JAMA (1973) 0.79
Circulating anticoagulant in the procainamide-induced lupus syndrome. Arch Intern Med (1977) 0.79
The phase II urokinase-streptokinase pulmonary embolism trial: a national cooperative study. Thromb Diath Haemorrh (1975) 0.79
Hematologic abnormalities in pregnancy. Med Clin North Am (1977) 0.79
The human plasmin-derived light (B) chain X streptokinase complex: a second-generation thrombolytic agent. Thromb Haemost (1983) 0.79